ReviewFrontiers in physiology2026
Innovations in skeletal muscle regeneration: from physiology to bioengineering approaches for repair and restoration.
Review in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skeletal muscle is a dynamic tissue essential for voluntary movement, metabolism, and thermoregulation. Yet, its intrinsic regenerative capacity is overwhelmed in volumetric muscle loss (VML), where damage exceeds the native repair threshold. Conventional treatments such as muscle flaps and grafts provide only partial structural and functional recovery, underscoring the need for regenerative strategies that more precisely recapitulate the molecular and cellular physiology of muscle healing. This review first outlines the physiology of injury and muscle regeneration, with emphasis on key molecular pathways that govern inflammation, fibrosis, and myogenesis in VML. Building on this biological framework, we then examine hydrogels as soft material platforms for skeletal muscle tissue engineering, including: (i) acellular hydrogels and nanoparticle-loaded hydrogels designed to modulate the biochemical and biophysical microenvironment; (ii) cell-loaded hydrogels that deliver myogenic or stem/progenitor cell populations; and (iii) drug-loaded hydrogels for localized, sustained release of growth factors, cytokines, nucleic acids, or small molecules. Finally, we discuss emerging directions, including nanoparticle-integrated systems, dynamically stiffening or softening hydrogels, and advanced biofabrication approaches, and consider how these cellularized and acellular drug-, cell-, or nanoparticle-loaded hydrogels can be strategically leveraged to treat complex skeletal muscle injuries.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.